Oxford interrupts trial of AstraZeneca COVID vaccine in children and adolescents due to blood clotting problem
The University of Oxford has stopped administering doses of the COVID-19 vaccine developed with AstraZeneca PLC AZN, -0.14% AZN, + 0.15% in a small study in the UK that aims to assess its safety an…
